|
|
|
|
| LEADER |
00000cam a2200000 4500 |
| 001 |
EBOOKCENTRAL_ocn877767242 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
140419s2013 enk ob 001 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d OCLCQ
|d EUW
|d J2I
|d YDXCP
|d OCLCF
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCA
|d NLE
|d AU@
|d OCLCO
|d OCLCA
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCA
|d MM9
|d SFB
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|
| 019 |
|
|
|a 853629126
|a 1290039464
|
| 020 |
|
|
|a 9781780841892
|
| 020 |
|
|
|a 1780841892
|
| 020 |
|
|
|a 9781780841908
|q (ePub)
|
| 020 |
|
|
|a 1780841906
|q (ePub)
|
| 020 |
|
|
|z 9781780841915
|q (print)
|
| 024 |
7 |
|
|a 10.2217/9781780841892
|2 doi
|
| 035 |
|
|
|a (OCoLC)877767242
|z (OCoLC)853629126
|z (OCoLC)1290039464
|
| 050 |
|
4 |
|a RC629 .G688 2013
|
| 060 |
|
4 |
|a WE 350
|b G688 2013eb
|
| 082 |
0 |
4 |
|a 616.3/999
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Dalbeth, Nicola.
|
| 245 |
1 |
0 |
|a Gout.
|
| 260 |
|
|
|a London :
|b Future Medicine Ltd,
|c 2013.
|
| 300 |
|
|
|a 1 online resource (246 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Title page; Copyright page; Contents; Foreword. Gout; 1. Epidemiology of gout; 2. Pathological basis of hyperuricemia and gout; 3. Pathophysiology and immunology of acute and chronic gout; 4. An update on the genetic causes of hyperuricemia and gout; 5. Clinical features of gout; 6. Synovial fluid analysis and crystal identification; 7. Imaging of gout; 8. Outcome measures in gout; 9. The patient's perspective of gout; 10. Asymptomatic hyperuricemia and its clinical implications for extra-articular disease; 11. Principles of gout management.
|
| 505 |
8 |
|
|a 12. Urate-lowering therapy: xanthine oxidase inhibitors13. Urate-lowering therapy: uricosurics; 14. Urate-lowering therapy: uricases; 15. Therapies for acute flares and gout flare prophylaxis; 16. Gout comorbidities: prevalence and management; 17. Emerging therapeutics for acute and chronic gout; Index.
|
| 500 |
|
|
|a Gout.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 546 |
|
|
|a English.
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a Gout.
|
| 650 |
1 |
2 |
|a Gout
|
| 650 |
|
6 |
|a Goutte (Maladie)
|
| 650 |
|
7 |
|a Gout
|2 fast
|
| 700 |
1 |
|
|a Perez-Ruiz, Fernando.
|
| 700 |
1 |
|
|a Schlesinger, Naomi.
|
| 758 |
|
|
|i has work:
|a Gout (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCGdTxTWBX4XjCGT7HDtcbm
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|a Dalbeth, Nicola.
|t Gout.
|d London : Future Medicine Ltd, ©2013
|z 9781780841915
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=1179648
|z Texto completo
|
| 936 |
|
|
|a BATCHLOAD
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL1179648
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 11775474
|
| 994 |
|
|
|a 92
|b IZTAP
|
